Muravleva, O. V.Pikul, K. V.Shaienko, Z. O.Муравльова, Оксана ВасилівнаПікуль, Катерина ВікторівнаШаєнко, Златослава Олексіївна2023-02-272023-02-272023Muravleva O. V. Diabetes therapy in wartime conditions / O. V. Muravleva, K. V. Pikul, Z. O. Shaienko // Modern research in world science : Proceedings of XI International Scientific and Practical Conference, Lviv, Ukraine 29–31 January 2023. SPC “Sci-conf.com.ua”. – Lviv, 2023. – Р. 119–121.978-966-8219-86-3https://repository.pdmu.edu.ua/handle/123456789/20163The article highlights the most urgent problem of endocrinology - diabetes mellitus (DM), which is spreading at a catastrophic rate, becoming a real epidemic of the XXI century. Metformin is a hypoglycemic drug that has proven its effectiveness in the treatment of type 2 diabetes for many years. Therefore, it is metformin that is stable in the choice of the drug of the first line of glucose-lowering therapy. Type 2 diabetes is one of the most common diseases characterized by metabolic disorders as a result of many pathophysiological processes. The leading pathophysiological disorder of type 2 diabetes is insulin resistance of muscle and adipose tissue together with pancreatic β-cell dysfunction. Further processes take place in adipose tissue, organs of the gastrointestinal tract, α-cells of the pancreas, and kidneys. All this leads to the development of chronic hyperglycemia.endiabetes mellitustype 2 diabeteschronic hyperglycemiaMetforminThesis001.1